India Focus Of Germany’s Boehringer In New-Drug Investment Move
This article was originally published in PharmAsia News
Executive Summary
India is being targeted by Boehringer Ingelheim for heavy investments in an effort to increase sales in what it views as Asia’s fastest-growing market for pharmaceuticals.